Celldex Therapeutics, Inc.·4

Aug 17, 4:05 PM ET

Wright Richard M. 4

4 · Celldex Therapeutics, Inc. · Filed Aug 17, 2022

Insider Transaction Report

Form 4
Period: 2022-08-15
Transactions
  • Exercise/Conversion

    Common Stock

    2022-08-15$10.38/sh+15,328$159,10515,536 total
  • Exercise/Conversion

    Incentive Stock Option

    2022-08-1515,32826,672 total
    Exercise: $10.38Exp: 2030-06-18Common Stock (15,328 underlying)
  • Sale

    Common Stock

    2022-08-15$37.71/sh15,328$578,048208 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.35 to $38.31 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  • [F2]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.

Documents

1 file
  • 4
    form4-08172022_010827.xmlPrimary